Opening closed inward rectifier potassium channel doors.

Area of Science:

• Molecular Biology
• Physiology
• Pharmacology

Background:

• Inwardly rectifying potassium (KIR) channels are crucial for regulating cell membrane potential in various tissues.
• Pathogenic mutations in KIR channels cause channelopathies, leading to loss-of-function phenotypes.
• Current pharmacological tools for activating KIR channels are limited, with rare subtype selectivity.

Purpose of the Study:

• To review current knowledge on KIR channel agonists.
• To focus on agonists that can address PIP2-dependent loss-of-function mutations.
• To highlight the need for subtype-specific KIR openers and PIP2-independent mechanisms.

Main Methods:

• Literature review of existing studies on KIR channel activators.
• Analysis of small molecules targeting specific KIR subtypes (e.g., ML297, GiGA1, VU0529331, GPV0057).
• Evaluation of therapeutic potential for channelopathies.

Main Results:

• Several small molecules show selective activation for certain KIR subtypes.
• No KIR channel activators have reached clinical trials.
• Key subtypes like KIR1.1 and KIR7.1 lack known openers.

Conclusions:

• There is an urgent need for subtype-specific KIR openers.
• Development of PIP2-independent activators and comprehensive preclinical studies are essential.
• Overcoming translational barriers could lead to new therapies for KIR channelopathies.